First reported by KELO-AM
Mylan to sell up to $363 million stake in India’s Biocon, term sheet shows
Biocon share price climbs 5% after block deals on NSE, BSE; key details
Biocon stock rose 4.96 per cent to Rs 430.95 apiece after sources had earlier indicated that the floor price for the block deal was set at Rs 378.50 per share, implying a 7.9 per cent discount to…
Read the full article3d agoen
You might also wanna read
Mylan to sell up to $363 million stake in India’s Biocon, term sheet shows
SINGAPORE, July 13 (Reuters) - Mylan Inc plans to sell up to 92 million shares in Indian drugmaker Biocon Ltd, worth up to 34.81 billion Ind
KELO-AM·3d ago
Biocon to see block deals, as Viatris plans to exit
Floor price has been fixed as ₹378.50 a share, a discount of 7.9 per cent to current price
thehindubusinessline.com·3d ago
Biocon shares jump 6% on reports of ₹3,481-crore block deal; Mylan likely to exit after 17 years
Fortune India·3d ago
Biocon Shares Rise After Mylan Exits Following Rs. 3,676-Crore Stake Sale
analyticsinsight·2d ago
A Look at Biogen Inc (BIIB) After 5.0% Gain -- GF Value $191.79 vs Price $209.03
Related Stocks: BIIB
GuruFocus·3d ago
Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants
WALTHAM, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. ("Crescent” or the "Company”) (Nasdaq: CBIO), a clinical-stage bi
Manila Times·2d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.